» Articles » PMID: 25995662

The Relationship Between Serum Asymmetric Dimethylarginine Levels and Subjective Sleep Quality in Normotensive Patients with Type 2 Diabetes Mellitus

Overview
Specialty General Medicine
Date 2015 May 22
PMID 25995662
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Poor sleep quality (SQ) is associated with increased cardiovascular mortality and morbidity. Additionally, asymmetric dimethylarginine (ADMA) is an independent predictor of cardiovascular mortality and morbidity. However, no sufficient data regarding the relationship between ADMA levels and SQ have been reported. The goal of the current study was to evaluate the association between SQ and ADMA levels in normotensive patients with type 2 diabetes mellitus.

Methods: The study participants consisted of 78 normotensive type 2 diabetics. The SQ of all participants was assessed using the Pittsburgh Sleep Quality Index (PSQI). Patients with a global PSQI score > 5 were defined as "poor sleepers." Factors associated with poor SQ were analyzed using a multiple regression model. Serum ADMA levels were measured using high performance liquid chromatography.

Results: The median ADMA levels of the poor sleepers were increased compared with patients defined as good sleepers (5.5 [4.2 to 6.6] vs. 4.4 [2.9 to 5.4], p < 0.01, respectively). However, the L-arginine/ADMA ratio was decreased in poor sleepers (p < 0.01). Global PSQI scores were positively correlated with ADMA levels (p < 0.01) and negatively correlated with the L-arginine/ADMA ratio (p = 0.02). ADMA levels were correlated with sleep latency (p < 0.01) and sleep efficiency (p = 0.01). Logistic regression analysis showed that ADMA levels (odds ratio [OR], 1.68; 95% confidence interval [CI], 1.16 to 2.44; p = 0.01) and body mass index (OR, 1.15; 95% CI, 1.01 to 1.31; p = 0.04) were associated with poor SQ independently of glomerular filtration rate, sex, age, duration of diabetes, hemoglobin A1c, total cholesterol, and systolic blood pressure.

Conclusions: Self-reported SQ was independently associated with ADMA levels in normotensive patients with diabetes mellitus.

Citing Articles

The association between insomnia (related symptoms) and glycaemic control: a systematic review and meta-analysis.

Chen Y, Tong E, Rao Y, Yu E, Zeegers M, Wesselius A J Glob Health. 2025; 15:04016.

PMID: 39916567 PMC: 11803432. DOI: 10.7189/jogh.15.04016.


Dimethylarginines in acute myocardial infarction: Association with lifestyle, sociodemographic, and somatometric factors.

Chalioti V, Giannakoulis V, Papoutsi E, Megalou A, Kritikos K, Konstantopoulos P J Family Med Prim Care. 2021; 9(12):6234-6239.

PMID: 33681070 PMC: 7928140. DOI: 10.4103/jfmpc.jfmpc_1495_20.


Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta-Analysis.

Koopman A, Beulens J, Dijkstra T, Pouwer F, Bremmer M, van Straten A J Clin Endocrinol Metab. 2019; 105(3).

PMID: 31603475 PMC: 7110921. DOI: 10.1210/clinem/dgz065.


Sleep Quality and Cognitive Function in Type 1 Diabetes: Findings From the Study of Longevity in Diabetes (SOLID).

Gilsanz P, Lacy M, Beeri M, Karter A, Eng C, Whitmer R Alzheimer Dis Assoc Disord. 2019; 34(1):18-24.

PMID: 31567303 PMC: 7047548. DOI: 10.1097/WAD.0000000000000351.

References
1.
Almdal T, Scharling H, Skov Jensen J, Vestergaard H . The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. 2004; 164(13):1422-6. DOI: 10.1001/archinte.164.13.1422. View

2.
de Zambotti M, Covassin N, Sarlo M, De Min Tona G, Trinder J, Stegagno L . Nighttime cardiac sympathetic hyper-activation in young primary insomniacs. Clin Auton Res. 2012; 23(1):49-56. DOI: 10.1007/s10286-012-0178-2. View

3.
Buysse D, Reynolds 3rd C, Monk T, BERMAN S, Kupfer D . The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28(2):193-213. DOI: 10.1016/0165-1781(89)90047-4. View

4.
Augustyniak R, Victor R, Morgan D, Zhang W . L-NAME- and ADMA-induced sympathetic neural activation in conscious rats. Am J Physiol Regul Integr Comp Physiol. 2005; 290(3):R726-32. DOI: 10.1152/ajpregu.00768.2004. View

5.
Irwin M, Wang M, Campomayor C, Collado-Hidalgo A, Cole S . Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med. 2006; 166(16):1756-62. DOI: 10.1001/archinte.166.16.1756. View